G-Protein Signaling Participates in the Development of Diabetic Cardiomyopathy
Authors:
- 1 December 2004
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 53 (12) , 3082-3090
Abstract
Diabetic patients develop a cardiomyopathy that consists of ventricular hypertrophy and diastolic dysfunction. Although the pathogenesis of this condition is poorly understood, previous studies implicated abnormal G-protein activation. In this work, mice with cardiac overexpression of the transcription factor peroxisome proliferator–activated receptor-α (PPAR-α) were examined as a model of diabetic cardiomyopathy. PPAR-α transgenic mice develop spontaneous cardiac hypertrophy, contractile dysfunction, and “fetal” gene induction. We examined the role of abnormal G-protein activation in the pathogenesis of cardiac dysfunction by crossing PPAR-α mice with transgenic mice with cardiac-specific overexpression of regulator of G-protein signaling subtype 4 (RGS4), a GTPase activating protein for Gq and Gi. Generation of compound transgenic mice demonstrated that cardiac RGS4 overexpression ameliorated the cardiomyopathic phenotype that occurred as a result of PPAR-α overexpression without affecting the metabolic abnormalities seen in these hearts. Next, transgenic mice with increased or decreased cardiac Gq signaling were made diabetic by injection with streptozotocin (STZ). RGS4 transgenic mice were resistant to STZ-induced cardiac fetal gene induction. Transgenic mice with cardiac-specific expression of mutant Gαq, Gαq-G188S, that is resistant to RGS protein action were sensitized to the development of STZ-induced cardiac fetal gene induction and bradycardia. These results establish that Gq-mediated signaling plays a critical role in the pathogenesis of diabetic cardiomyopathy.Keywords
This publication has 31 references indexed in Scilit:
- RGS4 Reduces Contractile Dysfunction and Hypertrophic Gene Induction in Gα qOverexpressing MiceJournal of Molecular and Cellular Cardiology, 2001
- Increased expression of Gαq protein in the heart of streptozotocin-induced diabetic ratsExperimental & Molecular Medicine, 1999
- RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overloadJournal of Clinical Investigation, 1999
- Selective Uncoupling of RGS Action by a Single Point Mutation in the G Protein α-SubunitJournal of Biological Chemistry, 1998
- RGS3 and RGS4 are GTPase Activating Proteins in the HeartJournal of Molecular and Cellular Cardiology, 1998
- RGS family members: GTPase-activating proteins for heterotrimeric G-protein α-subunitsNature, 1996
- Protein kinase C activity is altered in diabetic rat heartsBiochemical and Biophysical Research Communications, 1992
- Diabetes-induced cardiac changesTrends in Pharmacological Sciences, 1986
- Cardiac alpha- and beta-adrenergic receptor alterations in diabetic cardiomyopathyBasic Research in Cardiology, 1982
- Diabetes and cardiovascular disease. The Framingham studyJAMA, 1979